InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
InspireMD (NSPR) will present at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InspireMD (NSPR) will present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14 at 2:30 p.m. Eastern Time.
A live audio webcast and archived replay will be accessible via the investors page on the company’s website. Investors can contact their institutional representative to request a meeting or obtain additional conference details.
Details
News Market Reaction – NSPR
On Sep 3, the day this news came out, NSPR closed 0.29% above the previous close.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Conference date
- September 14th
- Upcoming H.C. Wainwright conference
- Presentation time
- 2:30 pm Eastern Time
- September 14th presentation
- Conference edition
- 28th annual
- H.C. Wainwright Global Investment Conference
Historical Context
-
Recall impacts and widened net loss accompanied second-quarter results.
-
Company scheduled its second-quarter results release and investor conference call.
-
Company approved restricted-stock inducement grants totaling 221,666 shares.
-
Kathleen Kennedy joined as senior vice president of global sales and marketing.
-
Company approved inducement grants covering 91,161 restricted shares.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14th at 2:30 pm Eastern Time (ET).
A live audio webcast and an archive of the recording will be available through the investors page of InspireMD’s corporate website at https://investors.inspiremd.com.
To request a meeting or for more details about the conferences, please reach out to your institutional contact.
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Jeff Warren
LifeSci Advisors
jwarren@lifesciadvisors.com
investor-relations@inspiremd.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.